During an initial reproductive endocrinology consultation, a 27-year-old woman seeks evalu… — USMLE Step 2 CK

During an initial reproductive endocrinology consultation, a 27-year-old woman seeks evaluation for an inability to conceive over the past 16 months. She previously experienced regular 28-day menstrual cycles, but they became progressively infrequent and completely ceased 8 months ago. Detailed history reveals that over the past year, the patient transitioned to a strict ketogenic diet and began high-intensity training for an ultramarathon, resulting in an intentional 9-kg weight loss. She notes a recent increase in mild facial acne. Her current body mass index is $19.8 \text{ kg/m}^2$ . Vital signs are within normal limits. Pelvic ultrasonography reveals a normal-appearing uterus and bilaterally enlarged ovaries, each containing 15 to 20 small, subcapsular follicles measuring 4 to 8 mm.

Laboratory studies show the following:
Follicle-stimulating hormone: 1.8 mIU/mL
Luteinizing hormone: 1.1 mIU/mL
Estradiol: 15 pg/mL
Prolactin: 9 ng/mL
Thyroid-stimulating hormone: 1.6 mU/L
Total testosterone: 25 ng/dL

Her partner's semen analysis is within normal limits. The patient strongly desires immediate pregnancy and strictly declines any modifications to her current diet or exercise regimen. Which of the following is the most appropriate pharmacologic intervention to induce ovulation in this patient?

A
Administration of clomiphene citrate
Administration of exogenous gonadotropinsAnswer
C
Administration of letrozole
D
Administration of medroxyprogesterone acetate
E
In vitro fertilization with donor oocytes

Answer

Administration of exogenous gonadotropins

This patient's presentation of secondary amenorrhea following intense exercise and weight loss, combined with low FSH, low LH, and low estradiol, is diagnostic of Functional Hypothalamic Amenorrhea (FHA). Her energy deficit has led to a suppression of hypothalamic GnRH pulsatility. While she exhibits mild acne and polycystic ovarian morphology (PCOM) on ultrasound—which can act as clinical red herrings for Polycystic Ovary Syndrome (PCOS)—her strictly normal testosterone and low gonadotropins firmly rule out PCOS. PCOM is a frequent incidental finding in FHA due to the lack of LH surges causing arrested follicular growth.

Because the patient declines lifestyle modifications (which is normally the first-line treatment for FHA), pharmacologic ovulation induction is necessary to treat her infertility. In a hypogonadotropic, hypoestrogenic state, the hypothalamus is fundamentally inactive. Therefore, medications that work by blocking estrogen negative feedback at the hypothalamus to increase endogenous GnRH (such as the aromatase inhibitor letrozole or the selective estrogen receptor modulator clomiphene) are completely ineffective. To achieve ovulation, the central defect must be bypassed by directly stimulating the ovaries with exogenous gonadotropins (FSH and LH) or by administering pulsatile GnRH.

Step-by-Step Solution

Analyze the patient's history and vital signs.

The patient has secondary amenorrhea and infertility following significant weight loss and intense endurance training, despite maintaining a normal BMI.

Intense exercise and caloric deficit are classic triggers for central suppression of the reproductive axis.

Interpret the laboratory and imaging findings.

Labs show hypogonadotropic hypogonadism (low FSH, LH, and estradiol) with normal prolactin, TSH, and testosterone. Ultrasound shows polycystic ovarian morphology (PCOM).

Accurate interpretation distinguishes Functional Hypothalamic Amenorrhea (FHA) from PCOS. PCOM is frequently seen in FHA due to arrested follicular development; however, the lack of hyperandrogenemia and the low gonadotropins rule out PCOS.

Determine the pathophysiological requirement for ovulation induction.

The pharmacological intervention must bypass the suppressed hypothalamus.

Because the hypothalamus is functionally suppressed by the energy deficit, drugs that rely on modifying central feedback mechanisms (like aromatase inhibitors or SERMs) will be ineffective.

Select the appropriate targeted therapy.

Administration of exogenous gonadotropins is chosen.

Since the patient refuses lifestyle modifications (the best initial step), direct stimulation of the ovaries with exogenous FSH/LH is required to achieve follicular development and ovulation.

Key Concept

Ovulation induction in Functional Hypothalamic Amenorrhea (hypogonadotropic hypogonadism) requires direct ovarian stimulation using exogenous gonadotropins or pulsatile GnRH, as the suppressed hypothalamus cannot respond to antiestrogen medications like letrozole or clomiphene.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic